GTR Home > Tests > Search results - C1867983[DISCUI]

Apply filters

Showing tests for all 2219 conditions

Compare labs

Your search term can be found in tests with a total of 2219 conditions. Only 1000 conditions are displayed in this filter box. Please type the name of the condition in the search box in this filter to find the specific condition. You can use the filters below to narrow down your results.
If the name of the condition you typed is not present, please try another query or search using the All GTR tab.

  • Hide states

GTR test search results for C1867983[DISCUI]

C Clinical test, R Research test

Showing 1 to 20 of 30 tests for 2219 conditions in 16 labs

CPorencephaly, familial

Lab: Centogene AG - the Rare Disease Company Rostock, Mecklenburg-Vorpommern, Germany
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CTruGenome Predisposition Screen (Whole Genome Sequencing)

Lab: Illumina Clinical Services Laboratory Illumina San Diego, California, United States
Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (1541)
Total targets (1578)

CComprehensive Epilepsy Panel

Lab: Transgenomic New Haven, Connecticut, United States
Total conditions (527)
Total targets (377)

CepiSEEK® Comprehensive Sequence Analysis for Epilepsy and Seizure Disorders (489 genes)

Lab: Courtagen Diagnostics Laboratory Courtagen Life Sciences Woburn, Massachusetts, United States
Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (641)
Total targets (439)

CFamilial vascular leukoencephalopathy

Lab: Bioarray Elche, Comunidad Valenciana, Spain
Test targets
Methods
  • C Sequence analysis of the entire coding region

CSingle gene testing COL4A1

Lab: CeGaT GmbH Tuebingen, Baden-Wurttemberg, Germany

CSmall vessel disease Panel

Lab: CeGaT GmbH Tuebingen, Baden-Wurttemberg, Germany
Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (11)
Total targets (5)

CBasal ganglia calcification Panel

Lab: CeGaT GmbH Tuebingen, Baden-Wurttemberg, Germany
Total conditions (53)
Total targets (27)

CCOL4A1 mutational analysis

Lab: Connective Tissue Laboratory Ghent University Hospital Ghent, Oost-Vlaanderen, Belgium
Test targets
Methods
  • E Sequence analysis of select exons

CPorencephaly gene panel

Lab: Connective Tissue Laboratory Ghent University Hospital Ghent, Oost-Vlaanderen, Belgium
Test targets
Methods
  • C Sequence analysis of the entire coding region

CCOL4A2 mutational analysis

Lab: Connective Tissue Laboratory Ghent University Hospital Ghent, Oost-Vlaanderen, Belgium
Test targets
Methods
  • E Sequence analysis of select exons

CCOL4A1

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CHemiplegia/Stroke NGS Panel

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Total conditions (28)
Total targets (10)

CEpilepsy Advanced Sequencing Evaluation

Lab: Athena Diagnostics Inc Quest Diagnostics Marlborough, Massachusetts, United States
Total conditions (143)
Total targets (141)

CEpilepsy Advanced Sequencing Evaluation - Neuronal Migration Disorders

Lab: Athena Diagnostics Inc Quest Diagnostics Marlborough, Massachusetts, United States
Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (29)
Total targets (29)

CEye Disorders: Comprehensive Sequencing and Deletion/Duplication Panel

Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (321)
Total targets (207)

Showing 1 to 20 of 30 tests for 2219 conditions in 16 labs

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.